Work

Malaria research and its influence on anti-malarial drug policy in Malawi: a case study

Year: 2026

Type: article

Abstract: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it had potentially led to early development of Plasmodium falciparum resistance to SP. This case study examined evidence from Malawi in order to assess if the policy changes were justifiable and supported by evidence.

Source: Human Science Research Council SA

DOI: 10.14749/32384724

Author: Human Sciences Research Council

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Human Sciences Research Council

OpenAlex ID: W7162192282

FWCI:

Cites:

Cited by:

Related to: